期刊文献+

淮南地区幽门螺杆菌对克拉霉素耐药性及其耐药分子机制的研究 被引量:2

The resistance of Helicobacter pylori to clarithromycin in Huainan area and its molecular mechanism for drug-resistance
暂未订购
导出
摘要 目的探讨淮南地区幽门螺杆菌(Helimbacter pylori,Hp)对克拉霉素耐药情况及其耐药分子机制。方法用E-test和琼脂稀释法进行克拉霉素药敏试验,提取Hp基因组DNA,PCR扩增Hp 23S rRNA基因,并用PCR-限制性片段长度多态性(RFLP)分析克拉霉素耐药机制。结果淮南地区克拉霉素耐药率为9.15%(27/141),克拉霉素耐药与性别、年龄无关。PCR从Hp基因组DNA中扩增出425bp的Hp 23S rRNA基因,PCR-RFLP检测,27株耐药菌株均可被Bbsl酶切成332、93bp两个片段,未检测到被BsaⅠ酶切的耐药菌株。结论淮南地区克拉霉素耐药率较高,耐药菌株存在23S rRNA基因功能区V2143位点A-G突变。 To understand the resistance of Helicobacter pylori to clarithromycin in Huainan area and to explore the molecular mechanism for drug-resistance,the susceptibility test of H pylori to clarithromycin was performed by means of E-test and the agar dilution method of assay. Meanwhile,the 23S rRNA V-domain gene of H pylori was amplified by PCR and the molecular mechanism for clarithromycin-resistance was analyzed by PCR-restriction fragment length polymorphism(RFLP). The results showed that the rate of clarithro...
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2008年第3期243-246,共4页 Chinese Journal of Zoonoses
基金 安徽省教育厅自然科学研究项目(No2006kj120C) 安徽省淮南市科技计划项目
关键词 幽门螺杆菌 克拉霉素耐药 分子机制 淮南地区 Helicobacter pylori clarithromycin resistance molecular mechanism Huainan
  • 相关文献

参考文献18

  • 1[1]Meyer JM,Silliman NP,Wang W,et al.Risk factors for Helicobacter pylori resistance in the United States:the surveillance of H.pylori antimicrobial resistance partnership(SHARP)study,1993-1999[J].Ann Intern Med,2002,136(1)13-24.
  • 2[2]Alessandra O,Maria U,Florence DP,et al.Macrolide Resistance in Helicobacter pylori:Rapid Detection of Point Mutations and Assays of Macrolide Binding to Ribosomes[J].Antimicro Agents and Chemother,1997,41(12):2724-2728.
  • 3[3]Glupczynski Y,Megraud F,Lopez-Brea M,et al.European multicenter survey of in vitro antimicrobial resistance in Helicobacter pylori[J].Eur J Clin Microbiol Infect Dis,2001,20(11):820-823.
  • 4郭燕,郭勤,沈守荣.幽门螺杆菌的耐药分析及对Hp根除的影响[J].中南药学,2005,3(5):270-272. 被引量:16
  • 5乔文,胡家露,彭道荣,孙怡群.西安地区幽门螺杆菌临床分离株耐药性研究[J].中国现代医学杂志,2002,12(6):48-49. 被引量:9
  • 6吕凤臣,赵月霞.抗幽门螺杆菌用药史与耐药率的相关性分析[J].临床内科杂志,2006,23(2):124-125. 被引量:11
  • 7成虹,胡伏莲,王蔚虹.108株幽门螺杆菌(Hp)菌株的耐药分析及其对Hp根除的影响[J].中国临床药理学杂志,2001,17(6):415-418. 被引量:66
  • 8刘改芳,徐华州,张玉贞,朱学梅,吴婧.幽门螺杆菌临床分离株耐药性研究[J].中国实用内科杂志,2005,25(2):130-131. 被引量:31
  • 9[9]Nicolas K,Michel B,Pierre HB,et al.High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children[J].J of Clin Microbiol,2001,39(1):394-397.
  • 10[10]Teresa A,Alba EV,Diego D,et al.Clarithromycin Resistance among Helicobacter pylori Strains Isolated from Children:Prevalence and Study of Mechanism of Resistance by PCR-Restriction Fragment Length Polymorphism Analysis[J].J Clin Microbiol,2003,41(1):486-488.

二级参考文献25

  • 1刘改芳,徐华州,张玉贞,朱学梅,吴婧.幽门螺杆菌临床分离株耐药性研究[J].中国实用内科杂志,2005,25(2):130-131. 被引量:31
  • 2胡伏莲.幽门螺杆菌感染治疗中的困惑与共识[J].中国实用内科杂志,2005,25(3):281-283. 被引量:45
  • 3胡文华,徐采朴.幽门螺杆菌菌株的7种药物体外药敏试验研究[J].第三军医大学学报,1996,18(5):457-458. 被引量:14
  • 4史碧山,佘菲菲,林赛榕,潘玉凤,江勇.幽门螺杆菌检测法比较及药敏试验[J].中华消化内镜杂志,1997,14(1):26-28. 被引量:60
  • 5龙北国 古惠英 龙敏 等.幽门螺杆菌的无血培养、传代和长期保藏.中华微生物学和免疫学杂志,1994,14(5):331-331.
  • 6Laine L,Suchower L,Frantz J,et al. low rate of emergence of Clarithromy-cin- resistant Helicobacter pylori with amoxycillin co-therapy. Aliment Pharmaco Ther,1998,12:887-892.
  • 7Cameron EA,Powell KU,Baldwin L,et al. Helicobacter pylori :antibiotic nesistance and eradication rates in Suffolk, UK, 1991-2001. J Med Microbiol,2004,53:535-538.
  • 8Masuda H,Hiyama T,Yoshihara M,et al. Characteriscits and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade.Pathobiology ,2004,71 : 159-163.
  • 9Megraud F.H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut ,2004,53:1374-1384.
  • 10Megraud F. Epidemiology and mechanism of antibiotic resistance in helicobacter pylori. Gastroenterology, 1998,115:1278-1282.

共引文献157

同被引文献20

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部